Published in Nat Methods on October 09, 2011
Robust enumeration of cell subsets from tissue expression profiles. Nat Methods (2015) 2.30
Defining cell-type specificity at the transcriptional level in human disease. Genome Res (2013) 1.96
Peripheral venous congestion causes inflammation, neurohormonal, and endothelial cell activation. Eur Heart J (2013) 1.60
Computational deconvolution: extracting cell type-specific information from heterogeneous samples. Curr Opin Immunol (2013) 1.40
MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma. Proc Natl Acad Sci U S A (2014) 1.25
Measuring cell-type specific differential methylation in human brain tissue. Genome Biol (2013) 1.19
Digital sorting of complex tissues for cell type-specific gene expression profiles. BMC Bioinformatics (2013) 1.18
Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders. Nat Rev Genet (2015) 1.14
Convergent genetic and expression data implicate immunity in Alzheimer's disease. Alzheimers Dement (2014) 1.12
Cell type-specific expression analysis to identify putative cellular mechanisms for neurogenetic disorders. J Neurosci (2014) 0.99
Ribosome profiling reveals a cell-type-specific translational landscape in brain tumors. J Neurosci (2014) 0.99
Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspective. Mol Neurobiol (2014) 0.96
Cell population-specific expression analysis of human cerebellum. BMC Genomics (2012) 0.95
A self-directed method for cell-type identification and separation of gene expression microarrays. PLoS Comput Biol (2013) 0.93
Age-related decreased inhibitory vs. excitatory gene expression in the adult autistic brain. Front Neurosci (2014) 0.91
Role of the NK cell-activating receptor CRACC in periodontitis. Infect Immun (2012) 0.88
Computational deconvolution of genome wide expression data from Parkinson's and Huntington's disease brain tissues using population-specific expression analysis. Front Neurosci (2015) 0.88
White blood cell differentials enrich whole blood expression data in the context of acute cardiac allograft rejection. Bioinform Biol Insights (2012) 0.85
The palmitoyl acyltransferase HIP14 shares a high proportion of interactors with huntingtin: implications for a role in the pathogenesis of Huntington's disease. Hum Mol Genet (2014) 0.85
CellCODE: a robust latent variable approach to differential expression analysis for heterogeneous cell populations. Bioinformatics (2015) 0.82
Increasing consistency of disease biomarker prediction across datasets. PLoS One (2014) 0.80
Mini but mighty: microRNAs in the pathobiology of periodontal disease. Periodontol 2000 (2015) 0.80
Identification of Vulnerable Cell Types in Major Brain Disorders Using Single Cell Transcriptomes and Expression Weighted Cell Type Enrichment. Front Neurosci (2016) 0.79
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease. Hum Mol Genet (2016) 0.78
A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome. Genome Biol (2016) 0.78
Mathematical modelling of transcriptional heterogeneity identifies novel markers and subpopulations in complex tissues. Sci Rep (2016) 0.78
ISOpureR: an R implementation of a computational purification algorithm of mixed tumour profiles. BMC Bioinformatics (2015) 0.78
Cell Type Specific Analysis of Human Brain Transcriptome Data to Predict Alterations in Cellular Composition. Syst Biomed (Austin) (2013) 0.78
Isolation and enhancement of a homogenous in vitro human Hertwig's epithelial root sheath cell population. Int J Mol Sci (2013) 0.77
Using mixtures of biological samples as process controls for RNA-sequencing experiments. BMC Genomics (2015) 0.76
Structural and molecular myelination deficits occur prior to neuronal loss in the YAC128 and BACHD models of Huntington disease. Hum Mol Genet (2016) 0.76
CellMapper: rapid and accurate inference of gene expression in difficult-to-isolate cell types. Genome Biol (2016) 0.76
Correspondence regarding Zhong et al., BMC Bioinformatics 2013 Mar 7;14:89. BMC Bioinformatics (2014) 0.75
Huntingtin facilitates selective autophagy. Nat Cell Biol (2015) 0.75
Epigenomic Deconvolution of Breast Tumors Reveals Metabolic Coupling between Constituent Cell Types. Cell Rep (2016) 0.75
Disease-specific classification using deconvoluted whole blood gene expression. Sci Rep (2016) 0.75
Improving sensitivity of linear regression-based cell type-specific differential expression deconvolution with per-gene vs. global significance threshold. BMC Bioinformatics (2016) 0.75
The frontline of immune response in peripheral blood. PLoS One (2017) 0.75
Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (2003) 100.88
affy--analysis of Affymetrix GeneChip data at the probe level. Bioinformatics (2004) 32.08
Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol (1985) 7.93
Cell type-specific gene expression differences in complex tissues. Nat Methods (2010) 4.75
Regional and cellular gene expression changes in human Huntington's disease brain. Hum Mol Genet (2006) 3.91
In silico dissection of cell-type-associated patterns of gene expression in prostate cancer. Proc Natl Acad Sci U S A (2004) 3.65
Expression deconvolution: a reinterpretation of DNA microarray data reveals dynamic changes in cell populations. Proc Natl Acad Sci U S A (2003) 3.19
Deconvolution of blood microarray data identifies cellular activation patterns in systemic lupus erythematosus. PLoS One (2009) 2.98
Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A (1988) 2.78
In silico microdissection of microarray data from heterogeneous cell populations. BMC Bioinformatics (2005) 2.26
Computational expression deconvolution in a complex mammalian organ. BMC Bioinformatics (2006) 2.18
Separation of samples into their constituents using gene expression data. Bioinformatics (2001) 2.02
ADAPT: a database of affymetrix probesets and transcripts. Bioinformatics (2005) 1.85
Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. J Nucl Med (2006) 1.83
Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical "disconnection". Neuroimage (2009) 1.72
Mixture models for assessing differential expression in complex tissues using microarray data. Bioinformatics (2004) 1.39
Overexpression of neuronal Sec1 enhances axonal branching in hippocampal neurons. Neuroscience (2002) 0.92
Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension. Science (2007) 5.23
Regional and cellular gene expression changes in human Huntington's disease brain. Hum Mol Genet (2006) 3.91
Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann Neurol (2006) 3.72
Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J Neurosci (2003) 3.67
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum Mol Genet (2007) 2.54
Complex reorganization and predominant non-homologous repair following chromosomal breakage in karyotypically balanced germline rearrangements and transgenic integration. Nat Genet (2012) 2.45
Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain. Proc Natl Acad Sci U S A (2003) 2.36
Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc Natl Acad Sci U S A (2013) 2.21
Comprehensive expression analyses of neural cell-type-specific miRNAs identify new determinants of the specification and maintenance of neuronal phenotypes. J Neurosci (2013) 2.08
Sustained effects of nonallele-specific Huntingtin silencing. Ann Neurol (2009) 2.05
Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets. Nat Med (2011) 1.97
HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration. PLoS Biol (2013) 1.96
Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease. J Clin Invest (2011) 1.66
A role for human brain pericytes in neuroinflammation. J Neuroinflammation (2014) 1.64
DNA instability in postmitotic neurons. Proc Natl Acad Sci U S A (2008) 1.61
Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain. Brain Res (2007) 1.50
The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity. J Biol Chem (2008) 1.46
Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice. Neurobiol Dis (2008) 1.38
Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood. Proc Natl Acad Sci U S A (2007) 1.35
The effect of neurodegenerative diseases on the subventricular zone. Nat Rev Neurosci (2007) 1.28
Neuroprotection by Hsp104 and Hsp27 in lentiviral-based rat models of Huntington's disease. Mol Ther (2007) 1.26
MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington's disease-related mechanisms. PLoS One (2013) 1.25
An ovine transgenic Huntington's disease model. Hum Mol Genet (2010) 1.24
Assessment of the relationship between pre-chip and post-chip quality measures for Affymetrix GeneChip expression data. BMC Bioinformatics (2006) 1.24
Distinct neuroinflammatory profile in post-mortem human Huntington's disease. Neuroreport (2009) 1.23
Dysregulation of gene expression in primary neuron models of Huntington's disease shows that polyglutamine-related effects on the striatal transcriptome may not be dependent on brain circuitry. J Neurosci (2008) 1.23
Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc Natl Acad Sci U S A (2002) 1.22
GPR105, a novel Gi/o-coupled UDP-glucose receptor expressed on brain glia and peripheral immune cells, is regulated by immunologic challenge: possible role in neuroimmune function. Brain Res Mol Brain Res (2003) 1.20
Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain. Eur J Neurosci (2004) 1.18
Isoform heterogeneity of the human gephyrin gene (GPHN), binding domains to the glycine receptor, and mutation analysis in hyperekplexia. J Biol Chem (2003) 1.17
A brain-permeable small molecule reduces neuronal cholesterol by inhibiting activity of sirtuin 2 deacetylase. ACS Chem Biol (2011) 1.17
The cellular composition and morphological organization of the rostral migratory stream in the adult human brain. J Chem Neuroanat (2008) 1.17
Cholinergic neuronal defect without cell loss in Huntington's disease. Hum Mol Genet (2006) 1.17
Gene expression profiles of metabolic enzyme transcripts in Alzheimer's disease. Brain Res (2006) 1.15
Decreased striatal RGS2 expression is neuroprotective in Huntington's disease (HD) and exemplifies a compensatory aspect of HD-induced gene regulation. PLoS One (2011) 1.15
Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis. Hum Mol Genet (2010) 1.14
HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation. Brain (2014) 1.13
Modulation of nucleosome dynamics in Huntington's disease. Hum Mol Genet (2007) 1.13
Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1. Hum Mol Genet (2004) 1.12
Glutamate uptake is reduced in prefrontal cortex in Huntington's disease. Neurochem Res (2007) 1.10
Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo. J Neurosci (2010) 1.10
Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease. Hum Mol Genet (2002) 1.09
Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease. Brain (2010) 1.08
Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 mice. J Neurosci (2007) 1.07
Gene expression profiling of R6/2 transgenic mice with different CAG repeat lengths reveals genes associated with disease onset and progression in Huntington's disease. Neurobiol Dis (2011) 1.07
What have we learned from gene expression profiles in Huntington's disease? Neurobiol Dis (2011) 1.05
Localization of glycine receptors in the human forebrain, brainstem, and cervical spinal cord: an immunohistochemical review. Front Mol Neurosci (2009) 1.04
Striosomes and mood dysfunction in Huntington's disease. Brain (2006) 1.02
Immunohistochemical staining of post-mortem adult human brain sections. Nat Protoc (2006) 1.01
Progenitor cells and adult neurogenesis in neurodegenerative diseases and injuries of the basal ganglia. Clin Exp Pharmacol Physiol (2007) 1.01
A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease. Hum Mol Genet (2014) 1.01
Cross-species and cross-platform gene expression studies with the Bioconductor-compliant R package 'annotationTools'. BMC Bioinformatics (2008) 1.00
Assessing RNA quality in postmortem human brain tissue. Exp Mol Pathol (2007) 0.99
A large number of protein expression changes occur early in life and precede phenotype onset in a mouse model for huntington disease. Mol Cell Proteomics (2008) 0.99
Neurogenesis in humans. Eur J Neurosci (2011) 0.98
Loss of SNAP-25 and rabphilin 3a in sensory-motor cortex in Huntington's disease. J Neurochem (2007) 0.97
Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease. PLoS One (2012) 0.97
Neurogenesis and progenitor cells in the adult human brain: a comparison between hippocampal and subventricular progenitor proliferation. Dev Neurobiol (2012) 0.96
M-CSF increases proliferation and phagocytosis while modulating receptor and transcription factor expression in adult human microglia. J Neuroinflammation (2013) 0.96
In vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons. Hum Mol Genet (2010) 0.96
Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons. J Neurochem (2009) 0.95
Comprehensive spatiotemporal transcriptomic analyses of the ganglionic eminences demonstrate the uniqueness of its caudal subdivision. Mol Cell Neurosci (2008) 0.94
HDAC4 does not act as a protein deacetylase in the postnatal murine brain in vivo. PLoS One (2013) 0.94
Extracellular signal-regulated kinase involvement in human astrocyte migration. Brain Res (2007) 0.92
Insoluble TATA-binding protein accumulation in Huntington's disease cortex. Brain Res Mol Brain Res (2002) 0.92
Diminished activity-dependent brain-derived neurotrophic factor expression underlies cortical neuron microcircuit hypoconnectivity resulting from exposure to mutant huntingtin fragments. J Pharmacol Exp Ther (2010) 0.91
The transcription factor PU.1 is critical for viability and function of human brain microglia. Glia (2013) 0.91
Molecular investigation of TBP allele length: a SCA17 cellular model and population study. Neurobiol Dis (2003) 0.90
N-terminal tripeptide of IGF-1 improves functional deficits after 6-OHDA lesion in rats. Neuroreport (2004) 0.90
MAP kinase phosphatase 1 (MKP-1/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition. J Neurosci (2013) 0.90
ABC efflux transporters in brain vasculature of Alzheimer's subjects. Brain Res (2010) 0.90
Adult human glia, pericytes and meningeal fibroblasts respond similarly to IFNy but not to TGFβ1 or M-CSF. PLoS One (2013) 0.89
Calpain hydrolysis of alpha- and beta2-adaptins decreases clathrin-dependent endocytosis and may promote neurodegeneration. J Biol Chem (2009) 0.89
Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo. Neurobiol Dis (2007) 0.89
Short-term striatal gene expression responses to brain-derived neurotrophic factor are dependent on MEK and ERK activation. PLoS One (2009) 0.89
The rostral migratory stream and olfactory system: smell, disease and slippery cells. Prog Brain Res (2009) 0.88
Identification and characterization of a novel splice variant of the metabotropic glutamate receptor 5 gene in human hippocampus and cerebellum. Brain Res Mol Brain Res (2002) 0.88
Cellular composition of human glial cultures from adult biopsy brain tissue. J Neurosci Methods (2007) 0.88
Striatal parvalbuminergic neurons are lost in Huntington's disease: implications for dystonia. Mov Disord (2013) 0.88
Comparative analyses of Purkinje cell gene expression profiles reveal shared molecular abnormalities in models of different polyglutamine diseases. Brain Res (2012) 0.87
A histochemical and immunohistochemical analysis of the subependymal layer in the normal and Huntington's disease brain. J Chem Neuroanat (2005) 0.87
Sox-2 is expressed by glial and progenitor cells and Pax-6 is expressed by neuroblasts in the human subventricular zone. Exp Neurol (2006) 0.87
Vascular degeneration in Parkinson's disease. Brain Pathol (2012) 0.87
Adult human brain neural progenitor cells (NPCs) and fibroblast-like cells have similar properties in vitro but only NPCs differentiate into neurons. PLoS One (2012) 0.87
Comparative cellular distribution of GABAA and GABAB receptors in the human basal ganglia: immunohistochemical colocalization of the alpha 1 subunit of the GABAA receptor, and the GABABR1 and GABABR2 receptor subunits. J Comp Neurol (2004) 0.87